SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001012168-97-000014
Filing Date
1997-04-15
Accepted
1997-04-15 00:00:00
Documents
1
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 SC 13D 72658
  Complete submission text file 0001012168-97-000014.txt   74746
Mailing Address 9393 TOWNE CENTRE DRIVE SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DR STE 100 SAN DIEGO CA 92121 6195353900
LIGAND PHARMACEUTICALS INC (Subject) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-43329 | Film No.: 97581430
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE MARITIME PLAZA SUITE 1325 SAN FRANCISCO CA 94111
Business Address ONE MARITIME PLZ STE 1325 SAN FRANCISCO CA 94111 4154212132
FARALLON CAPITAL MANAGEMENT LLC /ADV (Filed by) CIK: 0001012168 (see all company filings)

IRS No.: 943240279 | State of Incorp.: DE | Fiscal Year End: 1231